Arbutus Biopharma (ABUS) Depreciation and Depletion (2015 - 2021)
Arbutus Biopharma (ABUS) posted quarterly Depreciation and Depletion of $474000.0 for Q4 2021, down 6.88% year-on-year from $509000.0 in Q4 2020, and up 6.04% on a QoQ basis from $447000.0 in Q3 2021.
Arbutus Biopharma (ABUS) Depreciation and Depletion (2015 - 2021) Analysis & Trends
Arbutus Biopharma (ABUS) has reported Depreciation and Depletion for 7 consecutive years, with $474000.0 the latest figure, recorded in Q4 2021.
- Quarterly Depreciation and Depletion fell 6.88% year-over-year to $474000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.8 million (down 10.0% YoY) and the FY2025 annual result came in at $400000.0, down 71.43% from the prior year.
- Depreciation and Depletion climbed to $474000.0 in Q4 2021 per ABUS's latest filing, from $447000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for ABUS reached as high as $620000.0 in Q4 2017 and fell as low as $334000.0 in Q1 2017.
- A 5-year average of $501800.0 and a median of $502500.0 in 2018 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2017 — Depreciation and Depletion soared 103.78% — and 2018, when it slipped 18.71%.
- Year by year, Depreciation and Depletion stood at $620000.0 in 2017, then dropped by 18.71% to $504000.0 in 2018, then climbed by 0.6% to $507000.0 in 2019, then advanced by 0.39% to $509000.0 in 2020, then decreased by 6.88% to $474000.0 in 2021.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $474000.0, $447000.0, and $436000.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 474,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Sep 30, 2021 | 447,000.00 |
| Jun 30, 2021 | 436,000.00 |
| Jun 30, 2021 | 436,000.00 |
| Mar 31, 2021 | 443,000.00 |
| Mar 31, 2021 | 443,000.00 |
| Dec 31, 2020 | 509,000.00 |
| Dec 31, 2020 | 509,000.00 |
| Sep 30, 2020 | 490,000.00 |
| Sep 30, 2020 | 490,000.00 |
| Jun 30, 2020 | 501,000.00 |
| Jun 30, 2020 | 501,000.00 |
| Mar 31, 2020 | 500,000.00 |
| Mar 31, 2020 | 500,000.00 |
| Dec 31, 2019 | 507,000.00 |
| Dec 31, 2019 | 507,000.00 |
| Sep 30, 2019 | 507,000.00 |
| Sep 30, 2019 | 507,000.00 |